BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 10708948)

  • 1. The Smad pathway.
    Wrana JL; Attisano L
    Cytokine Growth Factor Rev; 2000; 11(1-2):5-13. PubMed ID: 10708948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway.
    Xu J; Attisano L
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4820-5. PubMed ID: 10781087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smads as transcriptional co-modulators.
    Attisano L; Wrana JL
    Curr Opin Cell Biol; 2000 Apr; 12(2):235-43. PubMed ID: 10712925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel link between the proteasome pathway and the signal transduction pathway of the bone morphogenetic proteins (BMPs).
    Lin Y; Martin J; Gruendler C; Farley J; Meng X; Li BY; Lechleider R; Huff C; Kim RH; Grasser WA; Paralkar V; Wang T
    BMC Cell Biol; 2002 Jun; 3():15. PubMed ID: 12097147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation.
    Zhu H; Kavsak P; Abdollah S; Wrana JL; Thomsen GH
    Nature; 1999 Aug; 400(6745):687-93. PubMed ID: 10458166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE; Schnaper HW; Poncelet AC
    J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FYVE domain in Smad anchor for receptor activation (SARA) is sufficient for localization of SARA in early endosomes and regulates TGF-beta/Smad signalling.
    Itoh F; Divecha N; Brocks L; Oomen L; Janssen H; Calafat J; Itoh S; Dijke Pt Pt
    Genes Cells; 2002 Mar; 7(3):321-31. PubMed ID: 11918675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling.
    Lin X; Liang M; Feng XH
    J Biol Chem; 2000 Nov; 275(47):36818-22. PubMed ID: 11016919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.
    Tsukazaki T; Chiang TA; Davison AF; Attisano L; Wrana JL
    Cell; 1998 Dec; 95(6):779-91. PubMed ID: 9865696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMAD destruction turns off signalling.
    Heldin CH; ten Dijke P
    Nat Cell Biol; 1999 Dec; 1(8):E195-7. PubMed ID: 10587654
    [No Abstract]   [Full Text] [Related]  

  • 11. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-dependent degradation of TGF-beta-activated smad2.
    Lo RS; Massagué J
    Nat Cell Biol; 1999 Dec; 1(8):472-8. PubMed ID: 10587642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remarkable versatility of Smad proteins in the nucleus of transforming growth factor-beta activated cells.
    Verschueren K; Huylebroeck D
    Cytokine Growth Factor Rev; 1999; 10(3-4):187-99. PubMed ID: 10647776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor.
    Ulloa L; Tabibzadeh S
    J Biol Chem; 2001 Jun; 276(24):21397-404. PubMed ID: 11278746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases.
    Morén A; Imamura T; Miyazono K; Heldin CH; Moustakas A
    J Biol Chem; 2005 Jun; 280(23):22115-23. PubMed ID: 15817471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling.
    Attisano L; Silvestri C; Izzi L; Labbé E
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):3-11. PubMed ID: 11451566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transduction of the TGF-beta superfamily by Smad proteins.
    Kawabata M; Miyazono K
    J Biochem; 1999 Jan; 125(1):9-16. PubMed ID: 9880789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signaling.
    Inoue Y; Kitagawa M; Onozaki K; Hayashi H
    J Interferon Cytokine Res; 2004 Jan; 24(1):43-54. PubMed ID: 14980084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into TGF-beta-Smad signalling.
    ten Dijke P; Hill CS
    Trends Biochem Sci; 2004 May; 29(5):265-73. PubMed ID: 15130563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFbeta signal transduction during transdifferentiation of hepatic stellate cells.
    Dooley S; Delvoux B; Streckert M; Bonzel L; Stopa M; ten Dijke P; Gressner AM
    FEBS Lett; 2001 Jul; 502(1-2):4-10. PubMed ID: 11478938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.